Management of Stroke in Patients With Chronic Liver Disease: A Practical Review

被引:4
作者
Parikh, Neal S. [1 ,2 ,7 ]
Basu, Elora
Hwang, Mu Ji [5 ]
Rosenblatt, Russel [3 ]
Vanwagner, Lisa B. [6 ]
Lim, Hana I. [4 ]
Murthy, Santosh B. [1 ,2 ]
Kamel, Hooman [1 ,2 ]
机构
[1] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Clin & Translat Neurosci Unit, New York, NY USA
[2] Dept Neurol, Weill Cornell Med, New York, NY USA
[3] Weill Cornell Med, Dept Internal Med, Div Gastroenterol & Hepatol, New York, NY USA
[4] Weill Cornell Med, Dept Internal Med, Div Hematol & Oncol, New York, NY USA
[5] Brown Univ, Dept Neurol, Providence, RI USA
[6] Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX USA
[7] Weill Cornell Med, 420 E 70th St, 4th Floor, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
cerebrovascular disorders; liver diseases; stroke; ACUTE ISCHEMIC-STROKE; DIRECT ORAL ANTICOAGULANTS; HEALTH-CARE PROFESSIONALS; VITAMIN-K ANTAGONIST; HEPATITIS-C VIRUS; FATTY LIVER; ATRIAL-FIBRILLATION; CIRRHOSIS; ASSOCIATION; SAFETY;
D O I
10.1161/STROKEAHA.123.043011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic liver disease (CLD) is a highly prevalent condition. There is burgeoning recognition that there are many people with subclinical liver disease that may nonetheless be clinically significant. CLD has a variety of systemic aberrations relevant to stroke, including thrombocytopenia, coagulopathy, elevated liver enzymes, and altered drug metabolism. There is a growing body of literature on the intersection of CLD and stroke. Despite this, there have been few efforts to synthesize these data, and stroke guidelines provide scant guidance on this topic. To fill this gap, this multidisciplinary review provides a contemporary overview of CLD for the vascular neurologist while appraising data regarding the impact of CLD on stroke risk, mechanisms, and outcomes. Finally, the review addresses acute and chronic treatment considerations for patients with stroke-ischemic and hemorrhagic-and CLD.
引用
收藏
页码:2461 / 2471
页数:11
相关论文
共 116 条
  • [1] Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome
    Abdeldyem, Sabry M.
    Goda, Tarek
    Khodeir, Samy A.
    Abou Saif, Sabry
    Abd-Elsalam, Sherief
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (04) : 915 - 919
  • [2] Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
    Alexander, Myriam
    Loomis, A. Katrina
    van der Lei, Johan
    Duarte-Salles, Talita
    Prieto-Alhambra, Daniel
    Ansell, David
    Pasqua, Alessandro
    Lapi, Francesco
    Rijnbeek, Peter
    Mosseveld, Mees
    Avillach, Paul
    Egger, Peter
    Dhalwani, Nafeesa N.
    Kendrick, Stuart
    Celis-Morales, Carlos
    Waterworth, Dawn M.
    Alazawi, William
    Sattar, Naveed
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [3] Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
    Arai, Taeang
    Atsukawa, Masanori
    Tsubota, Akihito
    Kato, Keizo
    Abe, Hiroshi
    Ono, Hirotaka
    Kawano, Tadamichi
    Yoshida, Yuji
    Tanabe, Tomohide
    Okubo, Tomomi
    Hayama, Korenobu
    Nakagawa-Iwashita, Ai
    Itokawa, Norio
    Kondo, Chisa
    Kaneko, Keiko
    Emoto, Naoya
    Nagao, Mototsugu
    Inagaki, Kyoko
    Fukuda, Izumi
    Sugihara, Hitoshi
    Iwakiri, Katsuhiko
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack
    Baik, Minyoul
    Nam, Hyo Suk
    Heo, Ji Hoe
    Park, Hyung Jong
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Lee, Hye Sun
    Kim, Seung Up
    Kim, Young Dae
    [J]. CEREBROVASCULAR DISEASES, 2020, 49 (05) : 474 - 480
  • [5] Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
    Baik, Minyoul
    Kim, Seung Up
    Kang, Sungwoo
    Park, Hyung Jong
    Nam, Hyo Suk
    Heo, Ji Hoe
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Lee, Hye Sun
    Kim, Young Dae
    [J]. CEREBROVASCULAR DISEASES, 2019, 47 (1-2) : 32 - 39
  • [6] Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
    Ballestri, Stefano
    Capitelli, Mariano
    Fontana, Maria Cristina
    Arioli, Dimitriy
    Romagnoli, Elisa
    Graziosi, Catia
    Lonardo, Amedeo
    Marietta, Marco
    Dentali, Francesco
    Cioni, Giorgio
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 1910 - 1932
  • [7] An assessment by the Statin Liver Safety Task Force: 2014 update
    Bays, Harold
    Cohen, David E.
    Chalasani, Naga
    Harrison, Stephen A.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (03) : S47 - S57
  • [8] Development and Evaluation of the Universal ACS NSQIP Surgical Risk Calculator: A Decision Aid and Informed Consent Tool for Patients and Surgeons
    Bilimoria, Karl Y.
    Liu, Yaoming
    Paruch, Jennifer L.
    Zhou, Lynn
    Kmiecik, Thomas E.
    Ko, Clifford Y.
    Cohen, Mark E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (05) : 833 - +
  • [9] Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure
    Cao, Yang
    Wang, Yuchen
    Zhou, Zhenqi
    Pan, Calvin
    Jiang, Ling
    Zhou, Zhiqiang
    Meng, Yonghong
    Charugundla, Sarada
    Li, Tao
    Allayee, Hooman
    Seldin, Marcus M.
    Lusis, Aldons J.
    [J]. SCIENCE, 2022, 377 (6613) : 1399 - +
  • [10] Cardiometabolic HFpEF: NASH of the Heart
    Capone, Federico
    Vettor, Roberto
    Schiattarella, Gabriele G.
    [J]. CIRCULATION, 2023, 147 (06) : 451 - 453